HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02

• Paloma Martín,

  Affiliation Group of Molecular Pathology, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯
• Isabel Krsnik,

  Affiliation Department of Hematology, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯
• Belen Navarro,

  Affiliation Department of Hematology, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯
• Mariano Provencio,

  Affiliation Department of Oncology, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯
• Juan F. García,

  Affiliation Department of Pathology, MD Anderson Cancer Center, Madrid, Spain

  ⨯
• Carmen Bellas,

  Affiliation Group of Molecular Pathology, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯
• Carlos Vilches ,

  ¶‡ These authors are shared senior authors on this work.

  Affiliation Group of Immunogenetics and Histocompatibility, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯
• Natalia Gomez-Lozano

  * E-mail: ngomez@idiphim.org

  ¶‡ These authors are shared senior authors on this work.

  Affiliation Group of Immunity and lymphoproliferative diseases, Instituto de Investigación Sanitaria Puerta de Hierro (IDIPHIM), Majadahonda, Spain

  ⨯